Midurethral Sling With Autologus Rectus… | Clinical Trial

Key information

Conditions

Stress Urinary Incontinence Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Lower Urinary Tract Symptoms Male Urogenital Diseases Pathological Conditions, Signs and Symptoms Signs and Symptoms Urinary Incontinence Urinary Incontinence, Stress Urination Disorders Urogenital Diseases Urologic Diseases Urological Manifestations

Age range

25 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Kasr El Ainiy Hospital

Cairo, 11562, Egypt

About this study

the rectus sheath is harvested in 5 cm length and 2 cm width , A 2cm width 8 cm length polypropolyine mesh is attached to the harvest rectus sheet sling on both side The procedure is carried with a similar technique to the outside in TOT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

stress incontinence

Exclusion criteria

overactive bladder

Treatment and study plan

rectus sheath midurethral sling

Procedure

Primary outcomes

cure rate of stress incontinence

Time frame: one year after surgery

history and urodynamic study

Sponsors and collaborators

Lead sponsor

sarah mohamed hassan

Other

Registry information

Official study title

The Safety And Efficacy Of Autologus Rectus Sheath Fascia As A Midurethral Transobturator Tension Free Vaginal Tape For Treatment Of Stress Urinary Incontinence.

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Mar 13, 2018
Registry last updated: Mar 16, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed